Dr. Michael I. Oppenheim, MD

Dr. Oppenheim practices at Northwell Health Physician Partners Cardiology in Manhasset, New York.

Dr. Oppenheim's NPI, 1831260835, was assigned on November 13, 2006. Dr. Oppenheim graduated from Yale School of Medicine in 1993. Dr. Oppenheim holds New York license 200119.

Dr. Oppenheim's primary practice is Northwell Health Physician Partners Cardiology, at 400 Community Dr, Manhasset, NY 11030 in Nassau County. The practice phone is (516) 321-7400.

Dr. Oppenheim's primary practice is Northwell Health Physician Partners Cardiology in Manhasset, New York. Dr. Oppenheim is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Oppenheim to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oppenheim practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Oppenheim's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Oppenheim is licensed in New York.

CMS data shows 61 Medicare services from Dr. Oppenheim across 1 procedure code in 2024, all of them office visits, for 57 Medicare patients. Medicare paid $3,016 for them. Every service was in an office.

CMS counts 57 Medicare patients who saw Dr. Oppenheim in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oppenheim's median patient age at 65, with 62% women.

In 2024, Dr. Oppenheim wrote 319 Medicare Part D claims for 51 patients. 93% of them were for generic drugs. CMS names the drug for 200 of them, across 9 drugs with 11 or more claims each, at $196,665 in total drug cost. In 2023, CMS named 134 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Oppenheim for performance year 2024, reported through an alternative payment model (APM). Dr. Oppenheim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oppenheim as offering telehealth.

Dr. Oppenheim graduated from Yale School of Medicine in 1993.